Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
< Previous
1
2
3
Next >
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
February 09, 2024
Tags
Retirement planning
Health Insurance
Aging
From
CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
General
pharmaceuticals
IONS
From
Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
December 04, 2023
Tickers
CBD
Tags
General
CBD
News
From
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Tickers
ACIU
BIIB
ESAIY
ESALY
Tags
News
Large Cap
Briefs
From
Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
September 30, 2023
Tags
Health Tips and Wellness Advice
Health
Alzheimer's disease
From
CNBC.com News
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
August 24, 2023
Tickers
TECH
Tags
News
Benzinga
Dr/ Itzhak Kurek
From
Benzinga
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
August 03, 2023
Tags
Alzheimer's disease
Science
Microsoft Corp
From
CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
Tickers
POTX
TOKE
Tags
Markets
Health Care
Benzinga
From
Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
July 20, 2023
Tags
Retiree finances
Elder care
Personal finance
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Science
Companies
Breaking news
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Social issues
US: News
Biotechnology
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Law and Regulation
Business News
US: News
From
CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
Tickers
ALZN
BIIB
LLY
SAVA
Tags
General
Benzinga
Health Care
From
Benzinga
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Biotechnology
Social issues
World News
From
CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
June 22, 2023
Tags
Abbvie (ABBV)
Teva Pharmaceuticals (TEVA)
atrial fibrillation
From
Stock Gumshoe
Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
June 21, 2023
Tags
FloraWorks
Alleh Lindquist
Financing
From
Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
US Economy
Eisai Co Ltd
Business
From
CNBC.com News
Medicare details plan to cover Alzheimer's treatments
June 01, 2023
Tags
US Economy
Business
Biotech and Pharmaceuticals
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Alzheimer's disease
Policy
Politics
From
CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023
Tags
Business News
Biotechnology
US: News
From
CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
May 03, 2023
Tags
Business
Biotech and Pharmaceuticals
Science
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Biogen Inc
Health care industry
Pharmaceuticals
From
CNBC.com News
March 2023 Miscellany
March 27, 2023
Tags
Eli Lilly (LLY)
Eisai (ESALY)
GlaxoSmithKline (GSK)
From
Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
January 17, 2023
Tags
Alzheimer's Disease
Anavex Life Sciences (AVXL)
NervGen Pharma (NGEN/V NGENF)
From
Stock Gumshoe
Relevant Updates – December 2022
December 27, 2022
Tags
Eisai (ESALY)
Biogen Idec (BIIB)
Merck (MRK)
From
Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
Tickers
MOR
RHHBF
RHHBY
RHHVF
Tags
RHHVF
why it's moving
Health Care
From
Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
November 13, 2022
Tags
Lifestyle
Longevity rates
Dementia
From
CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
November 07, 2022
Tickers
SPRC
Tags
General
SPRC
medical cannabis
From
Benzinga
Odd & Ends – October 2022
October 27, 2022
Tags
Eisai (ESALY)
Eli Lilly (LLY)
Biogen Idec (BIIB)
From
Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Tickers
ABOS
ACIU
ALZN
ANVS
Tags
Alzheimer's disease
Trading Ideas
CGTX
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.